Marco Guzzo
Overview
Explore the profile of Marco Guzzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
637
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferri M, Guzzo M, Omori H, Hazama Y, Masotta N, Botticelli D
Bioengineering (Basel)
. 2024 Nov;
11(11).
PMID: 39593737
Background: To prevent excessive compression of the cortical layer, which can lead to marginal bone loss, various companies have introduced specialized drills. However, these drills often lack the necessary precision,...
2.
Bergamini C, Cavalieri S, Resteghini C, Alfieri S, Nuzzolese I, Colombo E, et al.
Front Oncol
. 2023 Dec;
13:1298439.
PMID: 38074678
Background: Pregnancy-associated cancer (PAC) occurs during pregnancy or within 12 months after the delivery. Head and neck cancer (HNC) during pregnancy is infrequent, therefore diagnosis and personalized therapy are intricate....
3.
Resteghini C, Castelnuovo P, Nicolai P, Orlandi E, Bossi P, Vischioni B, et al.
Eur J Cancer
. 2023 May;
187:185-194.
PMID: 37164774
Purpose: Sinonasal tumours are rare diseases with poor prognosis. Multimodal approach including surgery is widely used, although no standard therapy has been established in prospective trials. This study assessed activity...
4.
Podda M, Meazza C, Gattuso G, Sironi G, Nigro O, Bergamaschi L, et al.
Tumori
. 2023 Mar;
109(5):436-441.
PMID: 36964667
Each year approximately 35,000 children and adolescents are diagnosed with cancer in Europe. Five-year survival rates have improved and now reach 80% in most European countries, thanks to a combination...
5.
Romanello D, Imamguliyeva Z, Cavalieri S, Vischioni B, Gandola L, Iannalfi A, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33327563
Clinical data of ri-SGCs patients treated between 2015 and 2019 at a tertiary cancer center and a national hadron therapy facility were reviewed. Latent time (LT) from first RT to...
6.
Iacovelli N, Cicchetti A, Cavallo A, Alfieri S, Locati L, Ivaldi E, et al.
Front Oncol
. 2020 Oct;
10:518110.
PMID: 33072562
This study aimed to look into the relationship between intensity-modulated-radiotherapy (IMRT)- or volumetric-modulated-arc-therapy (VMAT)-based dose-volume parameters and 5-year outcome for a consecutive series of non-metastatic nasopharyngeal cancer (NPC) patients (pts)...
7.
Campenni A, Barbaro D, Guzzo M, Capoccetti F, Giovanella L
Endocrine
. 2020 Aug;
70(2):280-291.
PMID: 32772339
Purpose: The standard of care for differentiated thyroid carcinoma (DTC) includes surgery, risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone therapy, and follow-up for detection of patients with persistent or...
8.
Raimondi A, Simeone N, Guzzo M, Maniezzo M, Collini P, Morosi C, et al.
ESMO Open
. 2020 Jul;
5(4).
PMID: 32661185
Objectives: Giant cell tumour of bone (GCTB) is a rare tumour, generally managed with surgery. Treatment of the very rare unresectable advanced/metastatic GCTB is challenging and denosumab is the only...
9.
Gatta G, Guzzo M, Locati L, McGurk M, Prott F
Crit Rev Oncol Hematol
. 2020 Jun;
152:102959.
PMID: 32485526
Salivary glands carcinomas are very rare epithelial malignant tumors. In 2013 in Europe, 7800 new diagnoses were estimated, 8.5 % of all head and neck cancer. The last WHO classification...
10.
Mozzanica F, Scarponi L, Rota M, Succo G, Crosetti E, Guzzo M, et al.
Disabil Rehabil
. 2019 Aug;
43(9):1307-1312.
PMID: 31442082
Objective: Speech impairment is common in patients affected by head and neck cancer and impact on quality of life. Therefore, specific instruments are required for its evaluation. The aim of...